Page 2 - Diabetes In India

Neck size may reveal more about your health than you realise, say doctors

Doctors highlight that a thicker neck may reflect hidden fat distribution in the body, raising chances of insulin resistance, high blood pressure, and cardiovascular disease

Eating French fries often raises diabetes risk, Harvard study warns

A study tracking 200,000 US adults reveals eating French fries three times a week can increase type 2 diabetes risk by 20% while boiled or baked potatoes show no such link when eaten in moderation

One-fifth of Indians aged 45 and above had diabetes in 2019: Study

About a fifth of those aged 45 and above were living with diabetes in 2019, with two in every five possibly unaware of their condition, according to data from a study among India's ageing adults. Findings published in The Lancet Global Health also suggest that as the country's population rapidly ages, diabetes cases among the middle-aged and older adults will increase, even if increase in prevalence of the condition in age-specific groups can be arrested, authors said. Researchers, including those from the International Institute for Population Sciences, Mumbai, and US, also found that 46 per cent of those aware of their diabetes regained a control over blood sugar levels, while around 60 per cent were able to control their blood pressure the same year. Six per cent were taking a lipid-lowering medication to reduce the risk of cardiovascular disease, the team said. The 'Longitudinal Aging Study in India' (LASI), which surveyed about 60,000 adults aged 45 and above during 2017-2019

Kitchen to bloodstream: 'Forever chemicals' may raise your diabetes risk

Mount Sinai findings link PFAS exposure to type 2 diabetes as the global numbers continue to surge at alarming levels

Why jamun seed powder is called a superfood for managing diabetes

Jamun seed powder contains jamboline and jambosine that help regulate blood sugar, support pancreatic function, and may aid in diabetes prevention if used correctly

Understanding gestational diabetes: Why early detection, awareness matter

Despite common misconceptions, gestational diabetes can affect healthy women of any age or body type. Often symptomless, it frequently goes undiagnosed-putting both mother and child at risk

Does your job involve meeting people? It may raise diabetes risk: Study

A 14-year study of nearly 3 million people found that emotional strain in public-facing roles may increase type 2 diabetes risk by up to 47 per cent

That 'healthy' juice habit? It might be messing with your metabolism

Think juice is better than soda? A large new study shows even 100% fruit juice raises diabetes risk, urging people to eat whole fruits instead

Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand

The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm Pharmarack Technologies

Novo Nordisk to launch weight-loss drug Wegovy in India ahead of schedule

Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in the Indian market

Can the '2 per 20' rule really help stabilise blood sugar without exercise?

Research shows that light walking for 2 minutes after every 20 minutes of sitting may significantly lower post-meal blood sugar levels

India's oil intake has tripled-how much is too much for your health?

India's per capita oil intake has jumped to 23.5 kg a year-nearly twice the ICMR's limit-raising health concerns over obesity, heart disease, and diabetes

Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what you need to know

Morepen Labs shares skyrocket 12% on rolling out 'Empamore'; details here

The uptick in the Morepen Labs share came after the company announced that it has rolled out 'Empamore.'

Glenmark launches Empagliflozin for diabetes in India under Glempa brand

Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes patients. The Mumbai-based drug firm has launched Empagliflozin, a widely recognised SGLT2 inhibitor, under the brand name Glempa (Empagliflozin 10/25 mg), along with its fixed-dose combinations (FDCs)'?Glempa-L (Empagliflozin 10/25 mg + Linagliptin 5 mg) and Glempa-M (Empagliflozin 12.5 mg + Metformin 500/1000 mg). The medications are designed to improve glycemic control in adults with type 2 diabetes mellitus while also reducing cardiovascular outcomes in patients with cardiovascular risk. Studies have demonstrated several benefits of Empagliflozin, including effectively improving glycemic control, supporting weight-loss, and reducing cardiovascular-renal risks in patients with type 2 diabetes mellitus. Empagliflozin has also demonstrated benefits in heart failure patients by lowering the cardiovascular death or hospitalisation. "The launch of Glempa range ..

ICMR sets up India's first diabetes biobank in Chennai for research

The country's first diabetes biobank, a repository of population-based biological samples aimed at supporting scientific research, has been established in Chennai by the Indian Council of Medical Research (ICMR) in collaboration with the Madras Diabetes Research Foundation (MDRF). The biobank set up at the MDRF, Chennai aims to gather, process, store and distribute biospecimens to assist scientific studies with the permission of the ICMR. The biobank will facilitate advanced research on the causes of diabetes, the variations of the Indian type of diabetes and related disorders, said Dr V Mohan, chairman of the MDRF and Dr Mohan's Diabetes Specialities Centre. The biobank has blood samples from two ICMR-funded studies -- the ICMR-?India Diabetes (ICMR-?INDIAB) study conducted in all states and Union territories in phases from 2008 to 2020 and the "Registry of people with diabetes in India at a young age at the onset", which was launched in 2006 and is still ongoing. A plethora of bl

Diabetes health insurance in India: Plans, coverage, and costs explained

Diabetes cannot prevent you from getting a policy. You must disclose it as a pre-existing illness, but insurers cannot deny cover solely on this basis

World Diabetes Day 2024: Theme, history and best winter foods for patients

Every year on November 14, we observe the World Diabetes Day (WDD) to increase awareness of diabetes, a chronic condition that affects millions of people worldwide

How fried and processed foods are fuelling India's diabetes epidemic

Indian diets, traditionally rich in whole grains, fruits, and vegetables, have shifted towards processed, fried, and sugar-laden foods, according to a recent government-backed study

Late-night sleepers face 50% greater risk of developing Type 2 diabetes

Staying up late increases Type 2 diabetes risk by nearly 50 per cent and is associated with higher BMI, larger waist circumference, and more visceral and liver fat